JP2013522652A - 代謝物プロファイリングを用いた再発乳癌の早期検出 - Google Patents

代謝物プロファイリングを用いた再発乳癌の早期検出 Download PDF

Info

Publication number
JP2013522652A
JP2013522652A JP2013501439A JP2013501439A JP2013522652A JP 2013522652 A JP2013522652 A JP 2013522652A JP 2013501439 A JP2013501439 A JP 2013501439A JP 2013501439 A JP2013501439 A JP 2013501439A JP 2013522652 A JP2013522652 A JP 2013522652A
Authority
JP
Japan
Prior art keywords
acid
sample
metabolite
panel
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013501439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013522652A5 (enExample
Inventor
ラフテリー、エム．ダニエル
モセティ アシアゴ、ビンセント
ゴウダ、ジー．エイ．ナガナ
アルバラード、ライディ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of JP2013522652A publication Critical patent/JP2013522652A/ja
Publication of JP2013522652A5 publication Critical patent/JP2013522652A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/38—Flow patterns
    • G01N30/46—Flow patterns using more than one column
    • G01N30/461—Flow patterns using more than one column with serial coupling of separation columns
    • G01N30/463—Flow patterns using more than one column with serial coupling of separation columns for multidimensional chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7206—Mass spectrometers interfaced to gas chromatograph
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013501439A 2010-03-23 2011-03-23 代謝物プロファイリングを用いた再発乳癌の早期検出 Pending JP2013522652A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31667910P 2010-03-23 2010-03-23
US61/316,679 2010-03-23
PCT/US2011/029681 WO2011119772A1 (en) 2010-03-23 2011-03-23 Early detection of recurrent breast cancer using metabolite profiling

Publications (2)

Publication Number Publication Date
JP2013522652A true JP2013522652A (ja) 2013-06-13
JP2013522652A5 JP2013522652A5 (enExample) 2014-05-08

Family

ID=44673604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013501439A Pending JP2013522652A (ja) 2010-03-23 2011-03-23 代謝物プロファイリングを用いた再発乳癌の早期検出

Country Status (7)

Country Link
US (1) US20130023056A1 (enExample)
EP (1) EP2550533A4 (enExample)
JP (1) JP2013522652A (enExample)
AU (1) AU2011232434B2 (enExample)
CA (1) CA2793735A1 (enExample)
MX (1) MX2012010852A (enExample)
WO (1) WO2011119772A1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015129776A (ja) * 2015-04-15 2015-07-16 ライオン株式会社 脂質異常症の判定方法
CN104991010A (zh) * 2015-07-29 2015-10-21 中国药科大学 一种区分乳腺癌亚型生物标志物的组合物
JP2017533413A (ja) * 2014-09-10 2017-11-09 アイディーシージーエス クリニカ デ ジアギノースチコス メディコス リミターダ 乳癌を評価するためのバイオマーカー
WO2017213246A1 (ja) * 2016-06-10 2017-12-14 株式会社日立製作所 尿中代謝物による疾病診断法
JP2018511811A (ja) * 2015-02-27 2018-04-26 オスモティック・ソチエタ・ア・レスポンサビリタ・リミタータ 子宮内膜癌の診断方法
JP2020101552A (ja) * 2013-10-28 2020-07-02 株式会社サリバテック 乳癌検出用唾液バイオマーカー、及び、これを用いた乳癌患者を健常者から識別する方法
KR20210055138A (ko) * 2019-11-06 2021-05-17 (의료)길의료재단 초음파 기법을 활용한 gc-ms 동시 분석 방법

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8653006B2 (en) 2010-09-03 2014-02-18 Purdue Research Foundation Metabolite biomarkers for the detection of esophageal cancer using NMR
US20140162903A1 (en) * 2012-10-31 2014-06-12 Purdue Research Foundation Metabolite Biomarkers For Forecasting The Outcome of Preoperative Chemotherapy For Breast Cancer Treatment
CN105451657A (zh) 2013-03-15 2016-03-30 霍罗吉克公司 用于导航断层合成堆叠的包括自动聚焦的系统和方法
WO2015109263A2 (en) 2014-01-17 2015-07-23 University Of Washington Biomarkers for detecting and monitoring colon cancer
MX2019002918A (es) 2016-09-16 2019-07-18 Dyax Corp Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto.
WO2018183548A1 (en) 2017-03-30 2018-10-04 Hologic, Inc. System and method for hierarchical multi-level feature image synthesis and representation
US11403483B2 (en) * 2017-06-20 2022-08-02 Hologic, Inc. Dynamic self-learning medical image method and system
TWI716093B (zh) * 2019-09-02 2021-01-11 高雄醫學大學 以代謝物標誌為基礎之預測乳癌復發風險的方法
CN112630363A (zh) * 2020-12-31 2021-04-09 四川大学华西医院 一种MXene生物响应特性代谢组学分析方法
WO2025118084A1 (en) * 2023-12-08 2025-06-12 Biomark Cancer Systems Inc. Early breast cancer detection using blood-based metabolomic profiling

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08248033A (ja) * 1995-02-15 1996-09-27 Bayer Corp 乳癌再発検出のための腫瘍マーカー群
JP2010537157A (ja) * 2007-07-17 2010-12-02 メタボロン インコーポレイテッド 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070221835A1 (en) * 2006-03-06 2007-09-27 Daniel Raftery Combined Spectroscopic Method for Rapid Differentiation of Biological Samples
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
US8980637B2 (en) * 2007-10-04 2015-03-17 Purdue Research Foundation Breast cancer biomarkers and identification methods using NMR and gas chromatography-mass spectrometry
CA2778226A1 (en) * 2009-10-09 2011-04-14 Carolyn Slupsky Methods for diagnosis, treatment and monitoring of patient health using metabolomics
EP2488666A4 (en) * 2009-10-13 2013-05-29 Purdue Research Foundation BIOMARKERS AND IDENTIFICATION METHOD FOR THE EARLY DETECTION AND PREDICTION OF THE REPRESENTATION OF BREAST CANCER BY NMR

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08248033A (ja) * 1995-02-15 1996-09-27 Bayer Corp 乳癌再発検出のための腫瘍マーカー群
JP2010537157A (ja) * 2007-07-17 2010-12-02 メタボロン インコーポレイテッド 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6014023236; ＮＭＲ　ｉｎ　Ｂｉｏｍｅｄｉｃｉｎｅ Ｖｏｌ．２３，　Ｐａｇｅ．４２４-４３１, 2010 *
JPN6014023239; Ｐｒｏｇ　Ｎｕｃｌ　Ｍａｇｎ　Ｒｅｓｏｎ　Ｓｐｅｃｔｒｏｓｃ Ｖｏｌ．４７，　Ｐａｇｅ．１６５-１７４, 2005 *
JPN6014023240; Ｍｅｔａｂｏｌｏｍｉｃｓ Ｖｏｌ．１，　Ｎｏ．３，　Ｐａｇｅ２６９-２７８, 2005 *
JPN6014023242; Ｎａｔ　Ｒｅｖ　Ｃａｎｃｅｒ Ｖｏｌ．４，　Ｎｏ．７，　Ｐａｇｅ．５５１-５６１, 2004 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020101552A (ja) * 2013-10-28 2020-07-02 株式会社サリバテック 乳癌検出用唾液バイオマーカー、及び、これを用いた乳癌患者を健常者から識別する方法
JP2017533413A (ja) * 2014-09-10 2017-11-09 アイディーシージーエス クリニカ デ ジアギノースチコス メディコス リミターダ 乳癌を評価するためのバイオマーカー
JP2018511811A (ja) * 2015-02-27 2018-04-26 オスモティック・ソチエタ・ア・レスポンサビリタ・リミタータ 子宮内膜癌の診断方法
JP2015129776A (ja) * 2015-04-15 2015-07-16 ライオン株式会社 脂質異常症の判定方法
CN104991010A (zh) * 2015-07-29 2015-10-21 中国药科大学 一种区分乳腺癌亚型生物标志物的组合物
WO2017213246A1 (ja) * 2016-06-10 2017-12-14 株式会社日立製作所 尿中代謝物による疾病診断法
JPWO2017213246A1 (ja) * 2016-06-10 2018-11-08 株式会社日立製作所 尿中代謝物による疾病診断法
KR20210055138A (ko) * 2019-11-06 2021-05-17 (의료)길의료재단 초음파 기법을 활용한 gc-ms 동시 분석 방법
KR102283623B1 (ko) 2019-11-06 2021-07-30 (의료)길의료재단 초음파 기법을 활용한 gc-ms 동시 분석 방법

Also Published As

Publication number Publication date
AU2011232434B2 (en) 2013-11-21
WO2011119772A1 (en) 2011-09-29
EP2550533A4 (en) 2014-01-08
US20130023056A1 (en) 2013-01-24
MX2012010852A (es) 2013-04-03
EP2550533A1 (en) 2013-01-30
CA2793735A1 (en) 2011-09-29
AU2011232434A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
AU2011232434B2 (en) Early detection of recurrent breast cancer using metabolite profiling
Wang et al. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma
Zhang et al. Mass spectrometry‐based “omics” technologies in cancer diagnostics
CN109946390B (zh) 一种肺癌诊断标志物组合及应用
US8653006B2 (en) Metabolite biomarkers for the detection of esophageal cancer using NMR
US20170023575A1 (en) Identification of blood based metabolite biomarkers of pancreatic cancer
CN113960235A (zh) 生物标志物在制备肺癌检测试剂中的用途和方法
US8518654B2 (en) Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect
Liu et al. Robust Glycoproteomics Platform Reveals a Tetra‐Antennary Site‐Specific Glycan Capping with Sialyl‐Lewis Antigen for Early Detection of Gastric Cancer
CN114544848B (zh) 一种用于诊断卵巢上皮癌的血清脂质标志物组合物及试剂盒和其与应用
CN111562338A (zh) 透明肾细胞癌代谢标志物在肾细胞癌早期筛查和诊断产品中的应用
Kałużna-Czaplińska et al. Current applications of chromatographic methods for diagnosis and identification of potential biomarkers in cancer
CN107003371A (zh) 用于确定主体患胰腺癌的可能性的方法
CN112305121B (zh) 代谢标志物在动脉粥样硬化性脑梗死中的应用
Massion et al. Proteomic strategies for the characterization and the early detection of lung cancer
US20140162903A1 (en) Metabolite Biomarkers For Forecasting The Outcome of Preoperative Chemotherapy For Breast Cancer Treatment
JP6421118B2 (ja) 前立腺摘出術後の前立腺癌の再発の診断のための手段および方法
CN120703370A (zh) 一种预测非小细胞肺癌免疫治疗疗效的血浆生物标志物
CN120590504A (zh) 预测非小细胞肺癌免疫治疗临床获益的生物标志物组合及其应用
CN119716028A (zh) 一种区分肺部非癌疾病和早期肺癌的血液标志物组合及其筛选方法和应用
CN113138275A (zh) 血清脂质代谢物组合物及试剂盒和应用
Ranasinghe et al. Fucosyl monosialoganglioside: Quantitative analysis of specific potential biomarkers of lung cancer in biological matrices using immunocapture extraction/tandem mass spectrometry
EP1477803A1 (en) Serum protein profiling for the diagnosis of epithelial cancers
CN116879558A (zh) 卵巢癌诊断标志物、检测试剂及检测试剂盒
AU2013231188A1 (en) Early detection of recurrent breast cancer using metabolite profiling

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140320

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140320

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20140326

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20140520

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140610

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150210